Targeting a key protein outside of the brain could help manage Parkinson's-related heart issues

The Portuguese pharmaceutical company BIAL has launched a new drug to treat episodes caused by Parkinson's disease in Portugal and Spain. The innovative film will respond to moments of blockage, contributing to improving the quality of...

Could targeting Parkinson's outside of the brain improve symptoms?

Parkinson's doesn't just affect movement and the brain -- it may also impact the heart, according to new research. Scientists suggest that targeting a key protein outside of the brain could help manage Parkinson's-related heart issues.

Targeting a key protein outside of the brain could help manage Parkinson's-related heart issues

Parkinson's doesn't just affect movement and the brain - it may also impact the heart, according to new research from the University of Surrey. Scientists from Surrey's School of Veterinary Medicine suggest that targeting a key protein outside of the brain could help manage Parkinson's-related heart issues.

An AI-enhanced treatment has reduced Parkinson’s symptoms for some people

The emerging therapy has virtually eliminated some patients most debilitating motor symptoms and considerably improved their quality of life. It has also enabled them to reduce their medication intake.

AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson's - Pharmaceutical Technology

At AD/PD 2025, Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinson’s disease (PD).

AI-powered Parkinson's treatment: Scientists propose new method Adaptive deep brain stimulation using AI significantly reduces motor symptoms of Parkinson's disease. The new method personalizes therapy based on the patient's brain activity in real time.